Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biomarkers in Cancer|July 17, 2019
Chemotherapy Resistance in Advanced Ovarian Cancer PatientsRuchika Pokhriyal, Roopa Hariprasad, Lalit Kumar, et al.Neuropsychiatric Disease and Treatment|October 22, 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And SchizophreniaAshish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, et al.Neuropsychiatric Disease and Treatment|August 15, 2019
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophreniaAshish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, et al.Biomarkers in Cancer|March 22, 2016
Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and PaclitaxelUrmila Sehrawat, Ruchika Pokhriyal, Ashish Kumar Gupta, et al.Journal of Central Nervous System Disease|October 18, 2018
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary StudyAshish Kumar Gupta, Komal Rani, Surabhi Swarnkar, et al.Neuropsychiatric Disease and Treatment|May 23, 2019
2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson's disease and schizophreniaAshish Kumar Gupta, Gaurav Khunger Kumar, Komal Rani, et al.Blood|December 14, 2023
Low-frequency inherited complement receptor variants are associated with purpura fulminansPavan K Bendapudi, Sumaiya Nazeen, Justine Ryu, et al.Pageof 1